VitaNova Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Cash & Equivalents	1.17	0.78	0.59	0.01	0.02	-
Cash & Short-Term Investments	1.17	0.78	0.59	0.01	0.02	-
Cash Growth	188.50%	32.00%	6694.64%	-62.22%	-	-
Receivables	1	1.27	-	-	-	-
Inventory	0.13	0.04	0.13	-	-	-
Other Current Assets	0.01	0.16	0.47	-	-	-
Total Current Assets	2.31	2.26	1.19	0.01	0.02	-
Total Assets	2.31	2.26	1.19	0.01	0.02	-
Accounts Payable	0.11	0.06	0.06	0.05	-	-
Accrued Expenses	0.08	-	-	-	0.05	0.03
Short-Term Debt	-	-	0	0.02	0.01	-
Current Income Taxes Payable	0.27	0.29	0.06	-	-	-
Other Current Liabilities	-	0	0.01	-	-	0.15
Total Current Liabilities	0.46	0.35	0.14	0.07	0.06	0.17
Total Liabilities	0.46	0.35	0.14	0.07	0.06	0.17
Common Stock	0.01	0.03	0.03	0.01	0.01	0.01
Additional Paid-In Capital	1.03	1.01	1.01	0.06	0.06	0.06
Retained Earnings	0.81	0.87	0.02	-0.12	-0.1	-0.24
Comprehensive Income & Other	0	0	0	-	-	-
Shareholders' Equity	1.85	1.91	1.06	-0.06	-0.03	-0.17
Total Liabilities & Equity	2.31	2.26	1.19	0.01	0.02	-
Total Debt	-	-	0	0.02	0.01	-
Net Cash (Debt)	1.17	0.78	0.59	-0.01	0.01	-
Net Cash Growth	285.56%	32.67%	-	-	-	-
Net Cash Per Share	0.14	0.09	0.17	-0.00	0.01	-
Filing Date Shares Outstanding	8.34	8.34	8.34	1.96	1.96	1.96
Total Common Shares Outstanding	8.34	8.34	8.34	1.96	1.96	1.96
Working Capital	1.85	1.91	1.06	-0.06	-0.03	-0.17
Book Value Per Share	0.22	0.23	0.13	-0.03	-0.02	-0.09
Tangible Book Value	1.85	1.91	1.06	-0.06	-0.03	-0.17
Tangible Book Value Per Share	0.22	0.23	0.13	-0.03	-0.02	-0.09